Anteris Technologies Ltd (AVR.AX)
AUD 9.04
(5.24%)
AUD 9.04
(5.24%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -28.49 Million AUD | -129.85% |
| 2022 | -12.39 Million AUD | 20.37% |
| 2021 | -15.57 Million AUD | -2624.96% |
| 2020 | -571.4 Thousand AUD | 91.0% |
| 2019 | -6.35 Million AUD | 47.23% |
| 2018 | -12.03 Million AUD | -245.04% |
| 2017 | -3.48 Million AUD | 69.02% |
| 2016 | -11.26 Million AUD | -27.77% |
| 2015 | -8.81 Million AUD | 63.32% |
| 2014 | -24.02 Million AUD | -22.69% |
| 2013 | -19.58 Million AUD | -700.8% |
| 2012 | -2.44 Million AUD | -19.64% |
| 2011 | -2.04 Million AUD | -53.52% |
| 2010 | -1.33 Million AUD | -0.36% |
| 2009 | -1.32 Million AUD | -7.89% |
| 2008 | -1.22 Million AUD | 13.93% |
| 2007 | -1.42 Million AUD | 32.83% |
| 2006 | -2.12 Million AUD | 21.65% |
| 2005 | -2.71 Million AUD | 19.26% |
| 2004 | -3.36 Million AUD | 9.58% |
| 2003 | -3.71 Million AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -10.59 Million AUD | 0.0% |
| 2023 FY | -28.49 Million AUD | -129.85% |
| 2023 Q2 | -17.28 Million AUD | 0.0% |
| 2023 Q4 | -28.49 Million AUD | 0.0% |
| 2022 Q2 | -29.02 Million AUD | 0.0% |
| 2022 Q4 | -12.39 Million AUD | 0.0% |
| 2022 FY | -12.39 Million AUD | 20.37% |
| 2021 FY | -15.57 Million AUD | -2624.96% |
| 2021 Q2 | 3.66 Million AUD | 0.0% |
| 2021 Q4 | -15.57 Million AUD | 0.0% |
| 2020 FY | -571.4 Thousand AUD | 91.0% |
| 2020 Q2 | -4.22 Million AUD | 0.0% |
| 2020 Q4 | -571.4 Thousand AUD | 0.0% |
| 2019 Q4 | -6.35 Million AUD | 0.0% |
| 2019 FY | -6.35 Million AUD | 47.23% |
| 2019 Q2 | -2.27 Million AUD | 0.0% |
| 2018 Q2 | 23.16 Thousand AUD | 0.0% |
| 2018 FY | -12.03 Million AUD | -245.04% |
| 2018 Q4 | -12.03 Million AUD | 0.0% |
| 2017 FY | -3.48 Million AUD | 69.02% |
| 2017 Q2 | -11.26 Million AUD | 0.0% |
| 2016 Q4 | -14.34 Million AUD | 0.0% |
| 2016 Q2 | -8.81 Million AUD | 0.0% |
| 2016 FY | -11.26 Million AUD | -27.77% |
| 2015 FY | -8.81 Million AUD | 63.32% |
| 2015 Q4 | -19.15 Million AUD | 0.0% |
| 2015 Q2 | -24.02 Million AUD | 0.0% |
| 2014 Q2 | -19.58 Million AUD | 0.0% |
| 2014 Q4 | -9.6 Million AUD | 0.0% |
| 2014 FY | -24.02 Million AUD | -22.69% |
| 2013 FY | -19.58 Million AUD | -700.8% |
| 2013 Q4 | -9.3 Million AUD | 0.0% |
| 2013 Q2 | -2.44 Million AUD | 0.0% |
| 2012 FY | -2.44 Million AUD | -19.64% |
| 2012 Q4 | -1.98 Million AUD | 0.0% |
| 2012 Q2 | -2.04 Million AUD | 0.0% |
| 2011 FY | -2.04 Million AUD | -53.52% |
| 2011 Q2 | -1.33 Million AUD | 0.0% |
| 2010 FY | -1.33 Million AUD | -0.36% |
| 2010 Q2 | -1.32 Million AUD | 0.0% |
| 2009 FY | -1.32 Million AUD | -7.89% |
| 2009 Q2 | -1.22 Million AUD | 0.0% |
| 2008 FY | -1.22 Million AUD | 13.93% |
| 2008 Q2 | -1.42 Million AUD | 0.0% |
| 2007 FY | -1.42 Million AUD | 32.83% |
| 2007 Q2 | -2.12 Million AUD | 0.0% |
| 2006 FY | -2.12 Million AUD | 21.65% |
| 2006 Q2 | -2.71 Million AUD | 0.0% |
| 2005 FY | -2.71 Million AUD | 19.26% |
| 2005 Q2 | -3.36 Million AUD | 0.0% |
| 2004 Q2 | -3.71 Million AUD | 0.0% |
| 2004 FY | -3.36 Million AUD | 9.58% |
| 2003 FY | -3.71 Million AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| 4DMedical Limited | -25.48 Million AUD | -11.824% |
| Adherium Limited | -6.1 Million AUD | -366.866% |
| Aroa Biosurgery Limited | -3.74 Million AUD | -660.553% |
| Atomo Diagnostics Limited | -3.6 Million AUD | -690.91% |
| Control Bionics Limited | -19.02 Thousand AUD | -149721.402% |
| CardieX Limited | 2.74 Million AUD | 1137.716% |
| Compumedics Limited | 5.08 Million AUD | 660.232% |
| Cochlear Limited | -269.9 Million AUD | 89.441% |
| CleanSpace Holdings Limited | 698.59 Thousand AUD | 4179.495% |
| Cyclopharm Limited | -7.49 Million AUD | -280.031% |
| EMVision Medical Devices Ltd | -15.7 Million AUD | -81.508% |
| Nova Eye Medical Limited | -2.8 Million AUD | -917.096% |
| HeraMED Limited | -799.34 Thousand AUD | -3465.284% |
| Imricor Medical Systems, Inc. | 14.48 Million AUD | 296.777% |
| ImpediMed Limited | -23.48 Million AUD | -21.329% |
| InhaleRx Limited | -155.54 Thousand AUD | -18222.164% |
| LBT Innovations Limited | -604 Thousand AUD | -4618.382% |
| Micro-X Limited | 826.99 Thousand AUD | 3546.078% |
| Neurotech International Limited | -2.11 Million AUD | -1250.358% |
| OncoSil Medical Limited | -4.43 Million AUD | -543.213% |
| PolyNovo Limited | -30.52 Million AUD | 6.643% |
| Respiri Limited | 413.68 Thousand AUD | 6988.998% |
| SomnoMed Limited | -15.16 Million AUD | -87.953% |
| Universal Biosensors, Inc. | -5.3 Million AUD | -437.318% |
| Uscom Limited | -1.53 Million AUD | -1761.911% |
| Visioneering Technologies, Inc. | -4.08 Million AUD | -598.001% |